EGF anticorps (pTyr869)
Aperçu rapide pour EGF anticorps (pTyr869) (ABIN5689753)
Antigène
Voir toutes EGF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr869
-
Specificité
- This antibody detects endogenous level of EGFR only when phosphorylated at tyrosine 869.
-
Purification
- Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
-
Immunogène
- EGFR (Phospho-Tyr869) antibody was raised against a peptide sequence around phosphorylation site of tyrosine 869 (K-E-Y (p) -H-A) derived from Human EGFR.
-
-
-
-
Indications d'application
- Western Blot: 1:500~1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store antibody at -20°C for up to one year.
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Autre désignation
- EGF
-
Sujet
- Receptor for EGF, but also for other members of the EGF family, as TGF-alpha, amphiregulin, betacellulin, heparin-binding EGF-like growth factor, GP30 and vaccinia virus growth factor. Is involved in the control of cell growth and differentiation. Phosphorylates MUC1 in breast cancer cells and increases the interaction of MUC1 with SRC and CTNNB1/beta-catenin.
-
Poids moléculaire
- 175 kDa
-
ID gène
- 1956
-
NCBI Accession
- NP_005219
-
UniProt
- P00533
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Antigène
-